Copy
Welcome to the Summer 2017 IAPRD Newsletter!
View this email in your browser
Visit the XXII Congress website
Note from Dr. Daniel Truong, President of the IAPRD
 
The XXII IAPRD Congress in Vietnam is only 4 months away, and we are gearing up for an excellent scientific program featuring many of the leaders in our field, as well as promising younger colleagues from around the world. The Congress will include plenty of time to “talk shop” and socialize in an exotic and extraordinary setting. There are only a few days left to submit an abstract, so please don’t delay. Travel grants are also available. I look forward to welcoming you at the Congress!
Halong Bay, Vietnam
Why Attend the XXII IAPRD Congress in Vietnam?

In keeping with our emphasis on Movement Disorders Around the Globe, we have assembled a truly international Faculty to provide breadth of viewpoints and experience. We are excited about our scientific program and hope you will be too!

The Congress will feature Melvin Yahr Lectures from Dr. Stanley Fahn on 200 Years of Movement Disorders and Prof. Drs. Joachim Krauss and Elena Moro on Deep Brain Stimulation Surgery in Movement Disorders: Lessons from the Last 3 Decades.

Our Plenary sessions will include discussions on biomarkers and cognitive function in movement disorders. Our Pho Hot Topic sessions (named in recognition of the famous Vietnamese hot soup, pho) will address burning topics such as gut microbiota in Parkinson’s disease and new therapeutic targets. The Point-Counterpoint sessions are designed to provide opposing viewpoints on controversial topics in our field (Is Parkinson disease a prion disease?). Back by popular demand are our Clinical Practice (educational) sessions that cover the movement disorder waterfront for clinicians. Global Video sessions will be videotaped and placed on our open-access, educational platform, which is set to launch later this year. Skills Workshops will cover topics that benefit from demonstration and hands-on learning, such as deep brain stimulation surgery and botulinum toxin injections. Last but certainly not least are our Timeline Parallel sessions that tackle important movement disorder concepts from the vantage points of past, present, and future.

We will also have time for discussions with colleagues that can lead to new insights, collaborations, and research interests. If you haven’t yet made arrangements to travel to Vietnam, we hope you will join us for didactics, discussion, and debate at this magical destination!
Upcoming Congress Deadlines
Additional Congress To-Do List
“Traveling – it leaves you speechless, then turns you into a storyteller.”
– Ibn Battuta
Quiz Question

Which of the following is NOT a recognized ocular/visual disturbance in Parkinson disease? Diplopia, Blue cone monochromacy, Decreased blink rate, Impaired color discrimination.   

Answer at end of newsletter
Words of Wisdom 
From Movement Disorder Expert, Dr. Mark Hallett
I was taught by two of my mentors, C. Miller Fisher and Ichiji Tasaki, not to believe anything unless I saw it for myself. This has been very good advice. Good to read the textbooks, but don’t fully accept what is written until you see it for yourself.  This is certainly also useful in research where, as has been emphasized recently, many research results are not reproducible. And it is valuable advice when seeing patients.  Several times I have seen patients where the diagnosis had been given some years before and then accepted without question by subsequent physicians. A look with a fresh eye might well reveal a different diagnosis. Of course, this can be due to evolution of the disorder, but sometimes the first physician was wrong. 
 
Editor's Choice Selections from
Parkinsonism & Related Disorders

Official Journal of the International Association of Parkinsonism and Related Disorders (IAPRD)
Merel S. Ekker, Sabine Janssen, Klaus Seppi, Werner Poewe, Nienke M. de Vries, Thomas Theelen, Jorik Nonnekes, Bastiaan R. Bloem. Vol. 40. Published online February 20, 2017.
Commentary provided by Zbigniew Wszolek, Editor-in-Chief, Department of Neurology, Mayo Clinic Florida, USA
Muneer Abu Snineh, Richard Camicioli, Janis M. Miyasaki, Vol. 39, Published online: March 8, 2017.
Commentary provided by Robert L. Rodnitzky, Associate Editor, Department of Neurology University of Iowa Hospital, USA
Arun Parashar, Malairaman Udayabanu, Vol. 38, Published online: February 7, 2017. 
Commentary provided by Ronald Pfeiffer, Editor-in-Chief, Dept. of Neurology, Oregon Health and Science University, USA
Up and Coming: Dr. Roberto Erro
Precision medicine is a hot topic in healthcare, and the field of movement disorders is no exception. Our featured Up and Coming researcher, Dr. Roberto Erro, makes it his business to understand and help define subtypes of Parkinson disease in his work as Assistant Professor of Neurology at the Center for Neurodegenerative Diseases (CEMAND), University of Salerno, Italy. Dr. Erro described his background and research interests in response to several interview questions.
 
How did you get interested in movement disorder research?
I must admit I have been lucky since it was by chance. In Italy you have to defend a thesis at the end of the medical school. I was assigned to a tutor who was in the field himself. It was a sort of imprinting, but it was only when I entered into my neurology training and started seeing patients that fell in love with movement disorders. I therefore officially joined the Movement Disorders Center at the University of Naples, Italy, under the supervision of Prof. Paolo Barone and became actively involved in research, attending congresses, meeting new people in the field, and getting inspired. Serendipity then brought me to join UCL, Queen Square, UK, with Prof. Kailash Bhatia for 3 fantastic years. After completing a PhD program in Neuroscience at the University of Verona, Italy, I got a position at the University of Salerno, near my hometown.
 
What are your current research interests?
My current research focus relates mainly to Parkinson disease subtyping. We have been looking at this issue primarily from the clinical standpoint, therefore leaving unanswered the question of what is the translational meaning of these subtypes. We routinely witness the heterogeneity and diverse faces of Parkinson disease, but do not understand why this happens and eventually treat patients in a paradoxically homogenous way. The ultimate goal is to understand why and how a particular set of symptoms occur in a given patient and develop specific (personalized) treatments.
 
What do you see as some of the important challenges in the field of movement disorders?
The whole nosology of movement disorders is being challenged by a constant stream of novel, mainly genetic, discoveries. It is not just about classifications, but is something that affects the way we approach patients with movement disorders, drives our hypotheses, and so on. I think this is the biggest challenge we are facing in the current days: It is a cultural challenge and it will require time for the entire community to adjust to this change.
IAPRD Nomination of Officers
Two positions must be filled on the IAPRD Board for next year: Secretary and Treasurer. These positions are open to full IAPRD members and require at least a 1-year commitment. Candidates must be willing to devote a reasonable amount of time to their duties and must respond rapidly and consistently to e-mails.

Dear IAPRD Members:

The time has come to formally open the election process for the two positions that must be filled at the General Assembly this November in Ho Chi Minh City. The two positions that must be filled are:

1) Secretary
2) Treasurer

The Bylaws of the IAPRD guide the nomination and election process and can be summarized as follows:

A) Any individual who is a full member of the IAPRD may be nominated.

B) Both the Board and one or more full members of the IAPRD are authorized to nominate candidates.

C) A candidate nominated by the Board is announced with the notification convening the meeting (Note: for this election, no candidate has been nominated by the Board).

D) Nominations of candidates by one or more full members must be submitted in writing to the Board, which has designated that the names be submitted to the Chair of the Nominating Committee, not later than 30 days prior to the start of the General Meeting, which for this election will be held during the International Congress in Ho Chi Minh City in November, 2017.

a. Please note that any suggestions for nominations that have been made in the IAPRD Forum are not formal nominations and will have no bearing on the formal election process outlined here; a formal nomination letter must be received.

b. Individuals nominated will be contacted to confirm that they are willing to be nominated and to serve if elected.

c. The Chair of the Nominating Committee is Ron Pfeiffer and the email address for submissions is pfeiffro@ohsu.edu.

E) The election will take place during the IAPRD General Meeting and will be determined by absolute majority of votes cast at the meeting.

F) Voting may be accomplished by proxy for full members who are unable to attend the General Meeting. To authorize a proxy, members must inform the Chairperson in writing at most 30 and not less than 7 days prior to the General Meeting.

If you have any questions regarding any of this, please feel free to contact me at the following email address: pfeiffro@ohsu.edu.

Sincerely,
Ron Pfeiffer
Chair, Nominations Committee
IAPRD

Ronald F. Pfeiffer, M.D.
Professor, Department of Neurology
Oregon Health & Science University

Mountain valley in northern Vietnam
Answer to Quiz Question:

Answer: Blue cone monochromacy. Click here to view a recent article on ocular and visual disorders in Parkinson's disease, published in Parkinsonism and Related Disorders.

 

IAPRD Newsletter Editorial Board
Angelo Antonini, MD, PhD
Vincenzo Bonifati, MD, PhD
Hubert Fernandez, MD
Karen Frei, MD
Andreas Puschmann, MD, PhD
Irena Rektorova, MD, PhD
Jon Stoessl, MD
Daniel Truong, MD
Erik Wolters, MD, PhD
Zbigniew Wszolek, MD
Mary Ann Chapman, PhD
Please feel free to forward this newsletter to interested colleagues. If you would like to become an Associate Member of the IAPRD, please visit the membership section of our website.

If you would like to be added or unsubscribed to the mailing list, or if you have comments on this newsletter, please contact Mary Ann Chapman, Executive Director, IAPRD at machapm@comcast.net. You can also unsubscribe by clicking on the unsubscribe link at the bottom of this page.

Vietnam images courtesy of Pixabay. 
Copyright © 2016 IAPRD, All rights reserved.

Our mailing address is:
van Eeghenstraat 83 
1071 EX Amsterdam 
The Netherlands

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list


 






This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
International Association of Parkinsonism and Related Disorders (IAPRD) · van Eeghenstraat 83 · Amsterdam, 1071 EX · Netherlands

Email Marketing Powered by Mailchimp